Tetramethylpyrazine suppresses lipid accumulation in macrophages via upregulation of the ATP-binding cassette transporters and downregulation of scavenger receptors.

Tetramethylpyrazine (TMP), a biologically active ingredient first extracted from the Chinese medicinal plant Ligusticum wallichii Franchat., has athero-protective activity, yet the particular mechanisms have not been completely explored. The present study was designed to investigate the effect of TMP and its possible mechanisms in RAW264.7 macrophages and apolipoprotein E-deficient (ApoE-/-) mice. TMP treatment markedly increased the cholesterol efflux and inhibited oxidized low-density lipoprotein (ox-LDL) uptake, thus, ameliorating lipid accumulation in macrophages. In addition, TMP significantly increased the protein and mRNA expression of ATP-binding cassette transporters A1 (ABCA1) and G1 (ABCG1), while suppressing the protein and mRNA expression of class A scavenger receptor (SR-A) and the cluster of differentiation 36 (CD36). Moreover, the effects of TMP on the upregulation of the expression of ABCA1 and ABCG1, the downregulation of the expression of CD36 and SR-A, the increase of cholesterol efflux and the decrease of lipid accumulation as well as the uptake of ox-LDL were mediated by the inactivation of PI3K/Akt and p38 MAPK. Furthermore, TMP upregulated the protein stability of ABCA1 without affecting ABCG1. Accordingly, TMP regulated the expression of SR-A, CD36, ABCA1 and ABCG1 in aortas of ApoE-/- mice, which resembled the findings observed in macrophages. TMP was also capable of delaying the progression of atherosclerosis in ApoE-/- mice. These findings revealed that TMP downregulates scavenger receptors and upregulates ATP-binding cassette transporters via PI3K/Akt and p38 MAPK signaling, thus suppressing lipid accumulation in macrophages.

[1]  D. Sylvester,et al.  Antithrombotic/antiplatelet activity of tetramethylpyrazine. , 1990, Thrombosis research.

[2]  Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. , 2001 .

[3]  Chao Yu,et al.  Paeonol suppresses lipid accumulation in macrophages via upregulation of the ATP‑binding cassette transporter A1 and downregulation of the cluster of differentiation 36. , 2015, International journal of oncology.

[4]  W. Weng,et al.  Tetramethylpyrazine in the treatment of cardiovascular and cerebrovascular diseases. , 1983, Planta medica.

[5]  Xin-en Huang,et al.  Anti-proliferation effects and molecular mechanisms of action of tetramethypyrazine on human SGC-7901 gastric carcinoma cells. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[6]  Y. Morikawa,et al.  T‐0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor‐deficient mice , 2003, FEBS letters.

[7]  Bo Sun,et al.  Icariin Attenuates High-cholesterol Diet Induced Atherosclerosis in Rats by Inhibition of Inflammatory Response and p38 MAPK Signaling Pathway , 2016, Inflammation.

[8]  Wenqiang Yan,et al.  A New Ligustrazine Derivative-Selective Cytotoxicity by Suppression of NF-κB/p65 and COX-2 Expression on Human Hepatoma Cells. Part 3 , 2015, International journal of molecular sciences.

[9]  C. Gabel,et al.  High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Siyu Chen,et al.  Ligustrazine improves atherosclerosis in rat via attenuation of oxidative stress , 2011, Pharmaceutical biology.

[11]  Chao Yu,et al.  Tetramethylpyrazine suppresses interleukin-8 expression in LPS-stimulated human umbilical vein endothelial cell by blocking ERK, p38 and nulear factor-kappaB signaling pathways. , 2009, Journal of ethnopharmacology.

[12]  R. Silverstein,et al.  Vav Family Rho Guanine Nucleotide Exchange Factors Regulate CD36-mediated Macrophage Foam Cell Formation* , 2011, The Journal of Biological Chemistry.

[13]  Paul T. Tarr,et al.  ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. , 2005, Cell metabolism.

[14]  O. Francone,et al.  Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. , 2001, The Journal of clinical investigation.

[15]  C. Fielding,et al.  Cellular cholesterol efflux. , 2001, Biochimica et biophysica acta.

[16]  H. Demura,et al.  Tetramethylpyrazine, a Chinese drug, blocks coronary vasoconstriction by endothelin-1 and decreases plasma endothelin-1 levels in experimental animals. , 1998, Journal of cardiovascular pharmacology.

[17]  Yu Huang,et al.  Tetramethylpyrazine Protects against Hydrogen Peroxide-Provoked Endothelial Dysfunction in Isolated Rat Aortic Rings: Implications for Antioxidant Therapy of Vascular Diseases , 2014, Evidence-based complementary and alternative medicine : eCAM.

[18]  B. Trigatti,et al.  HDL signaling and protection against coronary artery atherosclerosis in mice , 2015, Journal of biomedical research.

[19]  Y. Gui,et al.  Betulin attenuates atherosclerosis in apoE−/− mice by up-regulating ABCA1 and ABCG1 , 2016, Acta Pharmacologica Sinica.

[20]  M. Reilly,et al.  Pharmacological Activation of Liver X Receptors Promotes Reverse Cholesterol Transport In Vivo , 2005, Circulation.

[21]  C. Juan,et al.  VISFATIN PROMOTES FOAM CELL FORMATION BY DYSREGULATING CD36, SRA, ABCA1, AND ABCG1 EXPRESSION IN RAW264.7 MACROPHAGES , 2015, Shock.

[22]  R. Tiwari,et al.  IRAK regulates macrophage foam cell formation by modulating genes involved in cholesterol uptake and efflux , 2016, BioEssays : news and reviews in molecular, cellular and developmental biology.

[23]  Jing-Feng Wang,et al.  MCP-1 impacts RCT by repressing ABCA1, ABCG1, and SR-BI through PI3K/Akt posttranslational regulation in HepG2 cells[S] , 2013, Journal of Lipid Research.

[24]  K. J. Henley,et al.  ABCA12 regulates ABCA1-dependent cholesterol efflux from macrophages and the development of atherosclerosis. , 2013, Cell metabolism.

[25]  Lingna Kong,et al.  Kaempferol suppresses lipid accumulation in macrophages through the downregulation of cluster of differentiation 36 and the upregulation of scavenger receptor class B type I and ATP-binding cassette transporters A1 and G1. , 2013, International journal of molecular medicine.

[26]  Hongxu Liu,et al.  Effect of Compound Chuanxiong Capsule on Inflammatory Reaction and PI3K/Akt/NF-κB Signaling Pathway in Atherosclerosis , 2015, Evidence-based complementary and alternative medicine : eCAM.

[27]  S. Shyue,et al.  EGb761 ameliorates the formation of foam cells by regulating the expression of SR-A and ABCA1: role of haem oxygenase-1. , 2010, Cardiovascular research.

[28]  Jae-Yong Lee,et al.  Purple perilla extracts with α-asarone enhance cholesterol efflux from oxidized LDL-exposed macrophages , 2015, International journal of molecular medicine.

[29]  Chien-Sung Tsai,et al.  PKCδ signalling regulates SR-A and CD36 expression and foam cell formation. , 2012, Cardiovascular research.

[30]  Lei Wang,et al.  Tetramethylpyrazine Attenuates Atherosclerosis Development and Protects Endothelial Cells from ox-LDL , 2013, Cardiovascular Drugs and Therapy.

[31]  A. Orekhov,et al.  Macrophage‐mediated cholesterol handling in atherosclerosis , 2015, Journal of cellular and molecular medicine.

[32]  J. Huo,et al.  Effect of ligustrazine on mice model of hepatic veno‐occlusive disease induced by Gynura segetum , 2011, Journal of gastroenterology and hepatology.

[33]  S. Shyue,et al.  Molecular mechanism of curcumin on the suppression of cholesterol accumulation in macrophage foam cells and atherosclerosis. , 2012, Molecular nutrition & food research.

[34]  R. Bache,et al.  Coronary and Systemic Hemodynamic Effects of Tetramethylpyrazine in the Dog , 1985, Journal of cardiovascular pharmacology.

[35]  Jian-Dong Li,et al.  Vinpocetine attenuates lipid accumulation and atherosclerosis formation. , 2013, Biochemical and biophysical research communications.